Navigation Links
Journal 'STEM CELLS' Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
Date:6/19/2008

Dr. Motoda named for fundamental cancer stem cell discovery

DURHAM, N.C. and SEOUL, Korea, June 19 /PRNewswire/ -- The journal STEM CELLS(R) announces that Lena Motoda, M.D., Ph.D. won the 3rd Annual STEM CELLS(R) Young Investigator Award. Co-sponsored by The International Stem Cell Symposium, the $10,000 prize is annually given to a young scientist who is the principal author of a research paper published in STEM CELLS judged to be most important by a worldwide jury. A medical graduate of The University of Tokyo, Dr. Motoda received her Ph.D. degree for her Young Investigator Award winning research conducted at the Institute of Molecular and Cell Biology, National University of Singapore, with the mentorship of Associate Professor Motomi Osato and Professor Yoshiaki Ito. Dr. Motoda is currently in the Department of Pediatrics, Toranomon Hospital, Tokyo.

STEM CELLS published Dr. Motoda's landmark paper that describes the importance of "RUNX1" as a molecular guardian of stem cells that produce blood cells. RUNX1, a transcription factor protein, protects these vital cells from cancer-inducing molecular insults by maintaining fail-safe cellular mechanisms. This may offer new therapeutic options for blood cell malignancies like leukemia and lymphoma. The article is freely available online: http://stemcells.alphamedpress.org/cgi/content/full/25/12/2976 .

Professor Miodrag Stojkovic, co-editor of STEM CELLS, remarked that, "Dr. Motoda's discovery demonstrates, once again, why it is essential to understand basic molecular mechanisms since these revelations may both help prevent disease and enable the development of novel and hopefully more effective therapeutic options." To which Professor Donald Phinney, STEM CELLS' other co-editor, remarked, "The manuscript by Motoda and her colleagues is an excellent example of how molecular mechanisms that regulate
'/>"/>

SOURCE The AlphaMed Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Dermatology Nurses Association Teams with International Publisher to Launch its Own Journal
2. Long-term safety data on Lialda published in leading GI journal
3. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
4. American Heart Associations 3rd new journal -- Circulation: Cardiovascular Imaging
5. Harvard Study in Joint Commission Journal: Mortality Rates Lower in Leapfrog Hospitals
6. American Heart Associations Third New Journal - Circulation: Cardiovascular Imaging - Set for July Launch
7. American Heart Association Extends Sympathy to Family of Journalist Tim Russert
8. Essential dental treatment safe for pregnant women, says ADA journal study
9. MultiVu Video Feed: Study in the New England Journal of Medicine Shows High Blood Pressure Drug Tekturna(R) Reduces Key Marker of Kidney Disease
10. Journal of Ultrasound In Medicine features bioeffects consensus report
11. SAGE acquires 2 new medical journals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... Nov. 21 Today, prescrip...ention in treating 88 percent of patients sufferin... treated for a chronic condition account for 96 pe...cent of all medical costs. A proprietary new phar...lth Solutions, Inc. (NYSE: MHS ) significantly r...
(Date:11/21/2008)...and deadly diseaseits cause remains a mysteryswept...ing with citizens, soldiers and refugees of the wa...s filled with corpses, social order broke down. Ov...e and Athens lost a third of its population. It lo...ginning of the end of the Golden Age of Greece. ,...
(Date:11/21/2008)... Symmetry Medical Inc. (...roducts to the global orthopedic device industry a...an S. Moore, President and Chief Executive Officer...f Financial Officer, are scheduled to present at t...e at The New York Palace Hotel on Wednesday, Decem...
(Date:11/21/2008)..., N.Y. (Nov. 21, 2008) How can moss help us to t...mune system tell us about evolution? Can genetic ...s to conserve rare species? What can quail teach ... diseases? Will studies of choanoflagellates unra...d other questions in biology, scientists are incre...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:A new world of research possibilities with 'Emerging Model Organisms' 2
... University of New South Wales have found that dai...he risk// of developing dementia. Dementia is a p...ss of memory and daily activities leading to loss ... presence of irregular knots in brain cells, thoug...
...ive can worsen the clinical condition of cardiac p...ty can reverse the above situation and improve the...at physical activity can complicate a cardiac cond... and excessive strain on the heart. However, a gui...
...itage Insurance Co., the contractor that administe...re has accepted to cover its test. After this the...rose from $2.46 to $12.41 on Nasdaq. The company p...er test. The National Heritage Insurance Co. is t...
...ces the radiation time from six weeks to five days...ss convenient. Doctors// can point the radiation...e study compares the usefulness of the new therapy...t. They are also in the process of analyzing the s...
Other Medicine News:Health News:More Exercise Recommended For Fitness Of Cardiac Patients 2
(Date:11/20/2008)... BOSTON, Nov. 20 PAREXE...eading global biopharmaceutical services provider,...ima, Peru to provide regulatory consulting and cli...the Peru office, PAREXEL now has locations through...tin America, which also include Argentina, Brazil,...
(Date:11/19/2008)... , , Study did not achieve statistical si...wswire-FirstCall/ -- Pharmos Corporation (Nasdaq: ... clinical trial of its topical NanoEmulsion (NE) d...nac Diethanolamine. , , The multi-center, r...y evaluated the safety and efficacy of the Company...
(Date:11/19/2008)... -Triggers $5 Million Payment from Roche- , ,... -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY )...nt goal for its Phase 2 trial of R3487/MEM 3454, i...nitive impairment associated with schizophrenia (C...the Phase 2 trial, triggering a $5.0 million payme...
(Date:11/18/2008)... LANSDOWNE, Va., Nov. 18 /PRNewswire-USNewswire/ ...sts gathered at a November national forum to consi...ca,s public health and national economy from outbr...er announced today. , , Among those innovat...on every American kitchen table that detects highl...
Breaking Medicine Technology:PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Vendormate Again Selected as Top 40 Georgia Innovative Technology Company 13787 1Vendormate Again Selected as Top 40 Georgia Innovative Technology Company 13787 2New TB test means quicker and easier diagnosis for patients 13783 1New TB test means quicker and easier diagnosis for patients 13783 2New TB test means quicker and easier diagnosis for patients 13783 3Curing addiction with cannabis medicines 13779 1Curing addiction with cannabis medicines 13779 2Wandering albatrosses follow their nose 2438 1Wandering albatrosses follow their nose 2438 2
Paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients.
The Omni-Flex System provides the capability to change frame arms in the middle of surgery while retaining exposure with tension on the incision. The system is also strong enough to be stable for lar
These retractors, made of rugged Noryl® resin, are pre-sterilized and packaged singly in double peel-pouches for easy delivery to the sterile surgical field.
Pipetman Concept is a revolutionary motorized electronic pipette. Conceived with simplicity and flexibility in mind, Pipetman Concept features exclusive multifunction characteristics and a direct pip
Medicine Products: